Yutaka Morita

Tokushima, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

A case of thymic carcinoma harboring an FGFR3 S249C mutation with durable disease control on lenvatinib.

A case of thymic carcinoma harboring an FGFR3 S249C mutation with durable disease control on lenvatinib.

Journal: International cancer conference journal

Published: August 24, 2025

Immune checkpoint inhibitor-associated paraneoplastic cerebellar degeneration in a case of extensive-stage small-cell lung cancer with pre-existing anti-SOX1 antibody.

Immune checkpoint inhibitor-associated paraneoplastic cerebellar degeneration in a case of extensive-stage small-cell lung cancer with pre-existing anti-SOX1 antibody.

Journal: The journal of medical investigation : JMI

Published: April 23, 2025

A favorable antitumor efficacy of sotorasib in a patient with KRAS G12C-mutated pulmonary large-cell neuroendocrine carcinoma.

A favorable antitumor efficacy of sotorasib in a patient with KRAS G12C-mutated pulmonary large-cell neuroendocrine carcinoma.

Journal: International cancer conference journal

Published: March 04, 2025

Clock pathway inhibitor overcomes tumor immune-exclusion via regulation of fibrocyte differentiation.

Clock pathway inhibitor overcomes tumor immune-exclusion via regulation of fibrocyte differentiation.

Journal: NPJ precision oncology

Published: November 04, 2024

Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancer.

Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancer.

Journal: International journal of clinical oncology

Published: June 06, 2024

Hypoxia-inducible factor-targeting therapy augmented the sensitivity to programmed death ligand-1 blockade by enhancing interferon-γ-induced chemokines in tumor cells.

Hypoxia-inducible factor-targeting therapy augmented the sensitivity to programmed death ligand-1 blockade by enhancing interferon-γ-induced chemokines in tumor cells.

Journal: International journal of cancer

Published: May 03, 2024

Transformation of epidermal growth factor receptor mutated lung adenocarcinoma to small-cell carcinoma long after the cessation of tyrosine kinase inhibitor treatment: A case series and literature review.

Transformation of epidermal growth factor receptor mutated lung adenocarcinoma to small-cell carcinoma long after the cessation of tyrosine kinase inhibitor treatment: A case series and literature review.

Journal: Respiratory medicine case reports

Published: February 05, 2024

Surgical resection combined with perioperative chemotherapy for a patient with locally recurrent, previously stage IV thymic small-cell carcinoma: A case report.

Surgical resection combined with perioperative chemotherapy for a patient with locally recurrent, previously stage IV thymic small-cell carcinoma: A case report.

Journal: Thoracic cancer

Published: July 22, 2022

Pulmonary mycobacteriosis caused by Mycobacterium peregrinum: A case report.

Pulmonary mycobacteriosis caused by Mycobacterium peregrinum: A case report.

Journal: Medicine

Published: January 01, 2022

Radiation therapy induces an abscopal effect and upregulates programmed death-ligand 1 expression in a patient with non-small cell lung cancer.

Radiation therapy induces an abscopal effect and upregulates programmed death-ligand 1 expression in a patient with non-small cell lung cancer.

Journal: Thoracic cancer

Published: December 20, 2021

Showing 1-10 of 10

Last Updated: 09/26/2026